Search
Quantum BioPharma Ltd
QNTMAdd to Watchlist
2.890USD
+0.050+1.76%
Close 07-31 16:00（ET）Quotes delayed by 15 min
11.24MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Quantum BioPharma Ltd is 8.00, ranking 171 out of 385 in the Biotechnology & Medical Research industry. The average price target is 40.25, with a high of 45.00 and a low of 35.50.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
12.500
Target Price
+341.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Quantum BioPharma Ltd
QNTM
1
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Quantum BioPharma Ltd's expected revenue for the next quarter?
Quantum BioPharma Ltd's expected revenue is 1.90M.
What is Quantum BioPharma Ltd's price target?
Analysts forecast that Quantum BioPharma Ltd's price target is USD 40.25, with the highest forecast at USD 45.00 and the lowest forecast at USD 35.50.
How have Quantum BioPharma LtdQNTM's recent earnings per share performed?
The market expectation was USD -3.02, while Quantum BioPharma LtdQNTM's earnings per share (EPS) for the previous quarter was USD -0.79. EPS for the next quarter is expected at USD -0.42.
What is the analyst rating for Quantum BioPharma Ltd?
Based on the ratings of Quantum BioPharma Ltd's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.